Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA073581-01
Application #
2011596
Study Section
Special Emphasis Panel (SRC (C2))
Project Start
1996-09-30
Project End
2001-07-31
Budget Start
1996-09-30
Budget End
1997-07-31
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Microbiology/Immun/Virology
Type
Schools of Public Health
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Ivanovska, Iva; Hardwick, J Marie (2005) Viruses activate a genetically conserved cell death pathway in a unicellular organism. J Cell Biol 170:391-9
Irusta, Pablo M; Chen, Ying-bei; Hardwick, J Marie (2003) Viral modulators of cell death provide new links to old pathways. Curr Opin Cell Biol 15:700-5
Hardwick, J M; Bellows, D S (2003) Viral versus cellular BCL-2 proteins. Cell Death Differ 10 Suppl 1:S68-76
Bellows, David S; Howell, Melanie; Pearson, Colin et al. (2002) Epstein-Barr virus BALF1 is a BCL-2-like antagonist of the herpesvirus antiapoptotic BCL-2 proteins. J Virol 76:2469-79
Hardwick, J M; Levine, B (2000) Sindbis virus vector system for functional analysis of apoptosis regulators. Methods Enzymol 322:492-508
Bellows, D S; Chau, B N; Lee, P et al. (2000) Antiapoptotic herpesvirus Bcl-2 homologs escape caspase-mediated conversion to proapoptotic proteins. J Virol 74:5024-31
Chau, B N; Cheng, E H; Kerr, D A et al. (2000) Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1. Mol Cell 6:31-40
Hardwick, J M (1998) Viral interference with apoptosis. Semin Cell Dev Biol 9:339-49
Nava, V E; Cheng, E H; Veliuona, M et al. (1997) Herpesvirus saimiri encodes a functional homolog of the human bcl-2 oncogene. J Virol 71:4118-22
Cheng, E H; Nicholas, J; Bellows, D S et al. (1997) A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc Natl Acad Sci U S A 94:690-4